Mona-Elisabeth R. Revheim's research group: Functional and Molecular Imaging and Therapy
Group leader
Expanded knowledge of the pathogenesis behind diseases has led to the development of novel treatment strategies. Functional and molecular imaging modalities are promising for non-invasive diagnosis and evaluation of treatment response at an earlier time point than morphological imaging. The goals are to individualize diagnostic work-up and treatment, in order to optimize treatment outcome and minimize toxicity. The group focuses on:
- clinical- and translational studies
- how to optimize image quality and to improve accuracy of disease detection
- in vivo tissue characterization and depiction of disease process
- treatment response assessment
- multimodality imaging
- targeted radionuclide therapies
- theranostic medicine
- radiomics and artificial intelligence